Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.
Caldarola G, Pirro F, Di Stefani A, Talamonti M, Galluzzo M, D'Adamio S, Magnano M, Bernardini N, Malagoli P, Bardazzi F, Potenza C, Bianchi L, Peris K, De Simone C. Caldarola G, et al. Among authors: pirro f. Expert Opin Biol Ther. 2020 Jun;20(6):665-672. doi: 10.1080/14712598.2020.1727439. Epub 2020 Feb 17. Expert Opin Biol Ther. 2020. PMID: 32045273 Review.
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.
Zangrilli A, Caldarola G, Bernardini N, Bavetta M, Graceffa D, Bonifati C, Cantoresi F, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pirro F, Pagnanelli G, Panasiti V, Provini A, Richetta A, Sacchelli L, Bianchi L, Peris K. Zangrilli A, et al. Among authors: pirro f. Expert Opin Biol Ther. 2021 Sep;21(9):1291-1298. doi: 10.1080/14712598.2021.1948530. Epub 2021 Jul 18. Expert Opin Biol Ther. 2021. PMID: 34278889
A case of guttate psoriasis during treatment with dupilumab.
Gori N, Caldarola G, Pirro F, De Simone C, Peris K. Gori N, et al. Among authors: pirro f. Dermatol Ther. 2019 Sep;32(5):e12998. doi: 10.1111/dth.12998. Epub 2019 Jun 30. Dermatol Ther. 2019. PMID: 31215726 No abstract available.
Multiple paradoxical reactions during ixekizumab therapy.
Pirro F, Caldarola G, De Simone C, Moretta G, Giovanardi G, Peris K. Pirro F, et al. Dermatol Ther. 2019 May;32(3):e12852. doi: 10.1111/dth.12852. Epub 2019 Feb 27. Dermatol Ther. 2019. PMID: 30747476 No abstract available.
Risk of infections in psoriasis: assessment and challenges in daily management.
De Simone C, Fargnoli MC, Amerio P, Bianchi L, Esposito M, Pirro F, Potenza C, Ricceri F, Rongioletti F, Stingeni L, Prignano F. De Simone C, et al. Among authors: pirro f. Expert Rev Clin Immunol. 2021 Nov;17(11):1211-1220. doi: 10.1080/1744666X.2021.1997592. Epub 2021 Nov 1. Expert Rev Clin Immunol. 2021. PMID: 34696673 Review.
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study.
Pellacani G, Bigi L, Parodi A, Burlando M, Lanna C, Campione E, Rongioletti F, Mugheddu C, Malara G, Moretti G, Stingeni L, Hansel K, Micali G, Naldi L, Pirro F, Peris K. Pellacani G, et al. Among authors: pirro f. J Clin Med. 2022 Aug 16;11(16):4778. doi: 10.3390/jcm11164778. J Clin Med. 2022. PMID: 36013015 Free PMC article.
57 results